AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis as a treatment for a type of lung cancer. The US regulator cleared ...

Got mass appeal? Work the crowd! While Venus and Jupiter harmonize, you get noticed for all the right reasons. A bit of schmoozing does the trick today. Get eyes on your ideas by linking them to ...